Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solitary Pulmonary Nodule 1Smoking Cessation 1Ovarian Neoplasms 1Multiple Pulmonary Nodules 1Mesothelioma 1Lymphoma, B-Cell 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Cigarette Smoking 1Carcinoma, Renal Cell 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Oxygen 2Indocyanine Green 2Anterior Temporal Lobectomy 2belinostat 1Tomography, X-Ray Computed 1Thoracoscopy 1Technetium Tc 99m Aggregated Albumin 1Nitrous Oxide 1Methylene Blue 1Mastectomy, Segmental 1Magnetic Resonance Spectroscopy 1Hematologic Tests 1Fluorouracil 1Fluorodeoxyglucose F18 1Drug Delivery Systems 1Diagnostic Imaging 1Carbon Dioxide 1Blood Specimen Collection 1Anti-Bacterial Agents 14-fluoroglutamine 14-(3-fluoropropyl)glutamic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solitary Pulmonary Nodule × 4-(3-fluoropropyl)glutamic acid × Clear all
NCT02448225 2022-10-19

18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

Vanderbilt-Ingram Cancer Center

Phase 2 Completed
46 enrolled 12 charts
Thoracic

Cigarette Smoking, Solitary Pulmonary Nodule, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡